DCF — UH PARMA MEDICAL CENTER
Enterprise Value: $-383.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-383.7M
Enterprise Value
$-119.9M
PV of Cash Flows
$-263.8M
PV of Terminal Value
$-424.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $196.0M | $-24.7M | -13.0% | $-33.0M | $-30.0M |
| Year 2 | $201.9M | $-23.4M | -12.0% | $-32.0M | $-26.4M |
| Year 3 | $207.9M | $-22.1M | -11.0% | $-30.9M | $-23.2M |
| Year 4 | $214.1M | $-21.7M | -10.0% | $-30.7M | $-21.0M |
| Year 5 | $220.6M | $-21.8M | -10.0% | $-31.1M | $-19.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-383.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$190.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13111162837088708
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5